Independent research tool — not a government agency. Official notices govern.Refreshed
GrantsJunctionAmerican funding, sourcedMethodology
ForecastedOpportunity PAR-26-087

NEI New Innovator Award (DP2 Clinical Trial Not Allowed)

National Institutes of Health · Department of Health and Human Services

At a glance

NEI New Innovator Award (DP2 Clinical Trial Not Allowed) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of May 25, 2026; forecast dates can change. Applicant types listed as eligible include public colleges & universities, private colleges & universities and others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.867 (Vision Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Posted
Sep 23, 2025
Est. close date
May 25, 2026
Est. award date
Aug 2, 2026
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
Not specified
Expected awards
4
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary
Fiscal year
FY2026

Who can apply

  • Public colleges & universities
  • Private colleges & universities
  • Others (see notice)

Additional information on eligibility (from the notice)

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

The NEI New Innovator Award supports postdoctoral and other candidates in non-independent equivalent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research studies within the mission of NEI. Applications responding to this NOFO should have the potential to produce a major impact in vision research, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NEI. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged. 

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.867

Historical data · not a prediction
FY24$696M
FY25$703M
FY26$864K est.
Source: SAM.gov Assistance Listing 93.867. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Ed Clayton, Ph.D.
Ed.clayton@nih.gov
240-987-8255

Quick answers

Is “NEI New Innovator Award (DP2 Clinical Trial Not Allowed)” open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around December 1, 2025. Forecast details and dates can change.

Who is eligible to apply for “NEI New Innovator Award (DP2 Clinical Trial Not Allowed)”?

The official notice lists these applicant types as eligible: Public colleges & universities, Private colleges & universities and Others (see notice). Additional restrictions may apply; review the full notice.

How do I apply for “NEI New Innovator Award (DP2 Clinical Trial Not Allowed)”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity PAR-26-087), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.